IRadimed Corporation's latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Shows how the company performed in the first half of 2026, helping you understand if the business is growing.
Official announcement of Q2 earnings helps investors understand company performance and compare it to expectations.
Board members make big decisions about the company; knowing who leads helps you assess management quality.
Shows company earnings for Q1, helping you track whether the business is improving or declining.
Official Q1 earnings announcement lets investors see if the company is meeting financial goals.
Detailed yearly report explains how the company makes money and what problems could hurt its success.
Full-year earnings announcement shows overall 2025 performance before the new year begins.
Stocky reads IRadimed Corporation's official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
IRadimed Corporation's most recent tracked filing was a 10-Q on 31 Jul 2026: Second quarter 2026 financial results reported.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.